Cargando…
TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer
Metastasis is the most frequent cause of death in cancer patients. Epithelial-to-mesenchymal transition (EMT) is the process in which cells lose epithelial integrity and become motile, a critical step for cancer cell invasion, drug resistance and immune evasion. The transforming growth factor-β (TGF...
Autores principales: | Hua, Wan, ten Dijke, Peter, Kostidis, Sarantos, Giera, Martin, Hornsveld, Marten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256023/ https://www.ncbi.nlm.nih.gov/pubmed/31822964 http://dx.doi.org/10.1007/s00018-019-03398-6 |
Ejemplares similares
-
Metabolic Reprogramming of Mammary Epithelial Cells during TGF-β-Induced Epithelial-to-Mesenchymal Transition
por: Hua, Wan, et al.
Publicado: (2021) -
TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
por: Hao, Yang, et al.
Publicado: (2019) -
Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer
por: Zhang, Jing, et al.
Publicado: (2020) -
Metabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition
por: Jiang, Lei, et al.
Publicado: (2014) -
Opposing USP19 splice variants in TGF-β signaling and TGF-β-induced epithelial–mesenchymal transition of breast cancer cells
por: Zhang, Jing, et al.
Publicado: (2023)